Stopping antidepressants safely: network meta-analysis compares deprescribing strategies

elsa-olofsson-QwFyqPKyyY0-unsplash

This network meta-analysis of 76 trials found that slow tapering (over 4 weeks) combined with psychological support was most effective for preventing relapse when stopping antidepressants. Abrupt discontinuation and fast tapering substantially increased relapse risk and should be avoided.

[read the full story...]

Anticholinergics are associated with worse cognition: it’s time to take a serious look at our prescribing

A lot of pills in a pile

Eleanor Dawkins explores a new review and meta-analysis suggesting that cognitive impairment is linked with anticholinergic medication in psychosis, providing grounds for more careful monitoring and review of medications.

[read the full story...]

Antidepressant discontinuation symptoms: what do the data really tell us?

julia-zolotova-5ZofAm1f27E-unsplash

Gemma Lewis and Glyn Lewis summarise a robust systematic review and meta-analysis investigating the incidence of symptoms when discontinuing or withdrawing from antidepressants. The data suggest that 8-14% of patients will experience antidepressant discontinuation symptoms, and for around 2% these symptoms will be severe.

[read the full story...]

Risk factors for depression relapse while on long-term maintenance antidepressant treatment

danilo-alvesd-Y14ONzYtxb4-unsplash

In her debut blog, Asha Ladwa discusses a secondary analysis of data from the ANTLER trial, which investigated the clinical factors associated with relapse in primary care patients on long-term maintenance antidepressants.

[read the full story...]

Antidepressant withdrawal: recommendations for support from people with lived experience

pexels-polina-tankilevitch-3873190

Hannah Bowers summarises a study exploring the need for antidepressant withdrawal support, from 708 survey respondents with lived experience.

[read the full story...]

Uncertainties about stopping or reducing antipsychotics as shared by families

towfiqu-barbhuiya-w8p9cQDLX7I-unsplash

Amelia Talbot considers a qualitative study that explores family members’ perspectives on reducing or discontinuing antipsychotic medication.

[read the full story...]

Antidepressant withdrawal or depression relapse? International guidelines on antidepressant discontinuation are unclear

roberto-sorin-RS0-h_pyByk-unsplash

Adele Framer summarises a systematic review which finds that major guidelines on antidepressant discontinuation only give clinicians vague guidance on distinguishing withdrawal from relapse.

[read the full story...]

Psychotherapy and antidepressant tapering can help people at risk of depression relapse, but more evidence needed before we can provide personalised treatment

reza-biazar-eSjmZW97cH8-unsplash

Jessica Scaife reviews a individual patient data meta-analysis exploring the continuation of antidepressants versus sequential psychological interventions to prevent relapse in depression.

[read the full story...]

Expertise from outside the Academy: tapering off antidepressants

Senior,Man,Holding,Pharmaceutical,Pills,Over,Isolated,Background,With,Open

Mark Horowitz considers a recent article written by Adele Framer, Founder of SurvivingAntidepressants.org, which describes how best to help people who are tapering off antidepressants.

[read the full story...]

Antidepressant discontinuation and continuation: new Cochrane review finds miasma of confound

Depression.,Antidepressants.,Young,Character,Trapped,In,A,Pill,Bottle.,Capsules.

Adele Framer, Founder of SurvivingAntidepressants.org, explores a recent Cochrane review on antidepressant discontinuation versus continuation for adults with depression or anxiety, which highlights huge uncertainty in the science about antidepressant withdrawal.

[read the full story...]